GC Multi 5 Injection

Adult administration

Use as prescribed by a physician, adjusting the dosage according to the plasma trace element levels. - For patients receiving stable non-oral nutritional infusion: Zinc: 2.5-4mg per day Copper: 0.5-1.5mg per day Manganese: 0.15-0.8mg per day Chromium: 10-15µg per day Selenium: 20-40µg per day - Others: Patients with stable small bowel fluid loss: Additional 12.2mg/L (fluid loss amount)

Child administration

Pediatric patients - Under 5 years: Zinc 100µg/kg body weight per day Copper 20µg/kg body weight per day Manganese 2-10µg/kg body weight per day Chromium 0.14-0.20µg/kg body weight per day Selenium 3µg/kg body weight per day

This medication contains benzyl alcohol, which can cause fatal respiratory symptoms in premature infants, so it should not be used in newborns or premature infants. There is a risk of phlebitis; therefore, do not inject it directly in an undiluted state, and because it is a hypotonic solution, it must be used for mixed injections. If any component of this drug exhibits toxicity, administration should be stopped immediately, especially in patients with impaired renal function or premature infants due to the heightened risk of toxicity from aluminum. Before administration, the physician must confirm the patient's condition and metabolic requirements, and the serum trace element levels should be frequently measured to adjust the dosage. Patients with renal failure may have difficulty excreting zinc, potentially leading to zinc accumulation, and patients with biliary obstruction may accumulate copper and manganese, so caution is required. Patients with diabetes should check whether the chromium component affects glycemic control. Selenium requires dosage adjustment when administered to patients with renal or gastrointestinal dysfunction, and its safety has not been established in pregnant women, so it should only be used when the therapeutic benefit outweighs the risks. Excessive doses may lead to toxicity symptoms from zinc, copper, chromium, selenium, etc., and if symptoms occur, consultation with medical personnel should be sought immediately. This medication must be used according to a physician's prescription, and when added to non-oral nutritional infusions, aseptic conditions must be maintained. Before use, check for discoloration or the presence of particles in the solution, and it should not be used if abnormalities are found.

Serious side effects

• Hypotension
• jaundice
• decreased urine output
• severe edema
• coma

Mild side effects

• Sweating
• decreased consciousness
• blurred vision
• tachycardia
• hypothermia
• diarrhea
• vomiting
• hair loss
• weakened nails
• dermatitis

This drug should be stored in a sealed container to prevent air and moisture from entering, and it is best kept at room temperature between 15 and 30 degrees Celsius. Storing it this way will help maintain the drug's efficacy and ensure safe use.

Appearance

A colorless, odorless, or light blue transparent liquid contained in a colorless and transparent vial injection

Package unit

10mL × 10 vials